Analystreport

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview